36
Participants
Start Date
July 15, 2019
Primary Completion Date
August 1, 2022
Study Completion Date
March 1, 2023
Radiotherapy
Patients continue the same immune therapy they already received and get radiotherapy to one lesion. The lesion may or may not be symptomatic. The preferred radiotherapy dose is 24 Gy in 3 fractions (dosage on the 10 Gy isodose is allowed), but other fractionation schedules (e.g. 30 Gy/ 10 fractions, 20 Gy/ 5 fractions, 20-24 Gy / 1 fraction for SRS (stereotactic radiosurgery)) are allowed if these are standard for a certain location or palliative indication in the body.
Zuyderland Hospital, Heerlen
Maastricht University Medical Center, Maastricht
MAATRO clinic, Maastricht
The Netherlands Cancer Institute
OTHER
Maastricht University Medical Center
OTHER
Zuyderland Medical Centre
OTHER
Maastricht Radiation Oncology
OTHER